DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 2.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 21.5. According to RSI analysis, drreddy is oversold. 7.0 DRREDDY RSI Chart
MACD (?) MACD: -177.0 and Signal Line: -150.0. According to MACD analysis, drreddy is technically weak. 2.0 DRREDDY MACD Chart
Simple Moving Average (?) According to simple moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 2300.385, 2526.355, 2793.743. 0.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 2233.169, 2431.48, 2727.41. 0.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.209. According to bollinger bands, drreddy is technically weak. 3.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 2239.5447 and 2344.075. Support level is 1901.15. 2.5 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 74.6 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 52.9 which means DRREDDY's trend is ending soon. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
August 18, 2017
Open Price 1998.0
High Price 2007.55
Low Price 1971.3
Close Price 1982.0
Absolute Change -29.25
Percentage Change -1.45%
Weekly Change 1.93%
Monthly Change -27.9%
Yearly Change -34.2%
52-week high 3399.9
52-week low 1901.15
Corporate Actions
ExDate Purpose
July 17, 2017 AGM/DIV-RS 20 PER SHARE
July 10, 2015 AGM/DIV RS 20/- PER SHARE
July 11, 2014 AGM/DIV-RS 18 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.487
Confidence in Beta1.15%
Market Capital Rs. 33809.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 79.15
TTM Price-to-Earnings (P/E) Ratio 25
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 18 August 2017: Deliverable Quantity:1.19e+05 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 18 August 2017: Daily Volatility:0.4738 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 18 August 2017: PCR_OI:0.333 PCR:0.341 NA DRREDDY PCR Chart
Option Pain (?) 18 August 2017: Max Pain:2100.0 NA DRREDDY Option Pain Chart
Premium (?) 18 August 2017 Premium: 5.9 Futures OI:4250400.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 18 August 2017: Price:1982.0 Put with maximum OI:1900.0 Call with maximum OI:2200.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
August 31, 2017 1987.9 4250400.0 3259.0 3590.0 1982.0
September 28, 2017 2000.45 444200.0 363.0 444.0 1982.0

Announcements

August 14, 2017 Dr.Disclosure under SEBI Takeover Regulations. Reddy's Holdings Ltd has submitted to the Exchange, vide letter dated August 11, 2017 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
August 10, 2017 Dr.Updates. Reddy's Laboratories Limited has informed the Exchange that Intimation regarding betapharm Arzneimittel GmbH, Germany (our wholly-owned subsidiary) .
See all Announcements

Board Meetings

Date Meeting Date Purpose
July 05, 2017 July 27, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2017.
April 18, 2017 May 12, 2017 intResults/Dividendter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2017 and recommend dividend, if any, for the financial year 2016-17. Further, that the Company s trading window for dealing in securities by the Insiders is closed from April 26, 2017 and ending on May 14, 2017 (both days inclusive).
See all Board Meetings

DRREDDY is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 1930 Rs. 1951 Rs. 1966 Rs. 1987 Rs. 2003 Rs. 2023 Rs. 2039